Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ligelizumab (QGE 031), a high-affinity humanized monoclonal anti-IgE antibody, is utilized in the research of chronic spontaneous urticaria [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Ligelizumab (QGE 031), a high-affinity humanized monoclonal anti-IgE antibody, is utilized in the research of chronic spontaneous urticaria [1]. |
Synonyms | QGE 031, Anti-IGHE Recombinant Antibody |
Molecular Weight | N/A |
CAS No. | 1322627-61-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ligelizumab 1322627-61-1 QGE 031 QGE031 QGE-031 Anti-IGHE Recombinant Antibody inhibitor inhibit